Leah Brooks
Head of communications. press@keyline.xiobocreative.com
Media
News, contacts and our press kit.
For interviews, images and facts about Keyline, write to Leah Brooks, head of communications.
Media contact and facts
We reply to media requests within one business day.
About Keyline
Keyline Bio designs new proteins with AI for disease targets that are hard for other drug types to block. Its programs are investigational. The company was founded in 2023 and is based in Cambridge, MA.
Press kit
Logo files are below. Leadership photos and bios are on the Company page. Please do not change the logo or its colors.
Leadership →- Keyline mark, ink (SVG)
- Keyline mark, white (SVG)
- Ink #0B0F14
- Key amber #E8873A
- Paper #F3F4F1
Press releases
Press release
First patient dosed in the Phase 1 study of KL-101
Keyline's first clinical study is open in recurrent or metastatic head and neck cancer.
Press releaseKeyline raises $140M Series B
The funding supports the Phase 1 study of KL-101 and grows the design and lab platform.
Press releaseIND for KL-101 now in effect
Keyline can now start the first clinical study of a protein it designed.
Press releaseKeyline and Aldermoor start a partnership in autoimmune disease
Keyline will design binders for one target chosen by Aldermoor.